COVID-19 신속 검사 키트 시장 보고서(2024년)
COVID-19 Rapid Test Kits Global Market Report 2024
상품코드 : 1429381
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,000 ₩ 7,418,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,500 ₩ 11,127,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 ₩ 14,837,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

COVID-19 신속 검사 키트 시장 규모는 향후 몇 년동안 급격히 감소할 것으로 예상됩니다. 2028년에는 복합 성장률(CAGR) -84.4%로 9,000만 달러까지 감소할 것으로 예상됩니다. 예측 기간의 감소는 전문 기술 요구 사항, 보관 및 유통기한 고려, 경쟁 및 가격 압력, 공중 보건 시스템과의 통합, 대중의 인식 및 수용에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 기술 발전에 대한 집중, 빅데이터 활용에 대한 집중, 검사 대기 시간이 짧은 신속 검사 키트 개발에 대한 집중, 가정용 신속 검사 키트 개발에 대한 집중, 저비용 검사 키트 개발에 대한 집중 등을 들 수 있습니다.

정부의 규제와 진단 접근 방식을 다양화하려는 노력은 예측 기간 동안 COVID-19 신속 검사 키트 시장의 성장을 가속할 것으로 예상됩니다. 전 세계적으로, 특히 노인 인구가 증가함에 따라 코로나19 감염 확산에 대응하기 위해 더 나은 진단 시설의 필요성이 매우 중요해지고 있습니다. 2022년 4월 미국 식품의약국(FDA)은 임상시험에 과소평가된 인종 및 민족 집단에서 더 많은 참가자를 등록할 것을 강조하는 새로운 가이드라인 초안을 업계에 발표했습니다. 이 노력은 질병 퇴치를위한 개선 된 치료법과 전략 개발에서 다양한 커뮤니티의 의미있는 대표성을 보장하는 것을 목표로하며, COVID-19 진단 방법의 신속하고 혁신적인 개발을 위해 공공 및 민간 기관의 강력한 자금 지원과 투자로 인해 COVID-19 코로나19 진단키트 시장은 더욱 확대될 것으로 예상됩니다.

코로나19 신속 진단키트 시장의 예상 확대는 의료비 증가에 따른 의료비 증가에 힘입은 바 큽니다. 의료 시스템 또는 경제에서 의료 관련 상품 및 서비스에 대한 총 지출을 나타내는 의료 지출은 COVID-19 신속 검사 키트의 개발 및 접근성을 지원하는 데 중요한 역할을 합니다. 예를 들어, 캐나다 보건정보연구소(Canadian Institute for Health Information)의 2022년 11월 보고서에 따르면, 의료비 지출은 2021년 7.6%에서 0.8%로 증가하여 2022년 총 3,310억 달러에 달할 것으로 예상했습니다. 의료비 지출 증가 추세는 세계 경제 성장의 중요한 원동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

제5장 세계 시장 규모와 성장

제6장 시장 세분화

제7장 지역 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신 기업

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병(M&A)

제35장 향후 전망과 잠재성 분석

제36장 부록

LSH
영문 목차

영문목차

COVID-19 rapid test kits are user-friendly devices providing quick results, typically within 20 minutes. They come in two types such as rapid antigen test kits and rapid antibody test kits, manufactured by entities in the in-vitro rapid diagnostic tests sector of the medical equipment industry.

This market report segments the COVID-19 rapid test kits by test type into rapid antigen tests, rapid antibody tests, and other variants. Rapid antigen test kits specifically detect antigens associated with the COVID-19 virus. The segmentation by kit type includes equipment and extraction kits, as well as reagents. Specimen types involve nasopharyngeal swabs, oropharyngeal swabs, nasal swabs, blood samples, and others. End-users of these kits span hospitals, clinics, diagnostic laboratories, home care settings, and similar establishments.

The COVID-19 rapid test kits market research report is one of a series of new reports from The Business Research Company that provides COVID-19 rapid test kits market statistics, including COVID-19 rapid test kits industry global market size, regional shares, competitors with a COVID-19 rapid test kits market share, detailed COVID-19 rapid test kits market segments, COVID-19 rapid test kits market trends and opportunities, and any further data you may need to thrive in the COVID-19 rapid test kits industry. This COVID-19 rapid test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The COVID-19 rapid test kits market size has declined steeply in recent years. It will decline from $3.8 billion in 2023 to $0.59 billion in 2024 at a compound annual growth rate (CAGR) of -84.4%. The growth in the historic period can be attributed to sensitivity and specificity concerns, limited multiplexing capability, evolution of viral variants, supply chain disruptions, regulatory challenges.

The COVID-19 rapid test kits market size is expected to see steep decline in the next few years. It will decline to $0.09 billion in 2028 at a compound annual growth rate (CAGR) of -84.4%. The decline in the forecast period can be attributed to professional skill requirements, storage and shelf-life considerations, competition and price pressure, integration with public health systems, public perception and acceptance. Major trends in the forecast period include focus on technology advancements, focus on incorporating big data, focus on developing rapid test kits with low test wait times, focus on developing at-home rapid test kits and focus on developing low-cost test kits.

Government regulations and initiatives to diversify diagnostic approaches are expected to drive growth in the COVID-19 rapid test kits market during the forecast period. The need for better diagnostic facilities has become crucial to combat the increasing spread of COVID-19 cases globally, especially among the rising geriatric population. In April 2022, the Food and Drug Administration (FDA), a US-based government agency, issued new draft guidance to the industry, emphasizing the enrollment of more participants from underrepresented racial and ethnic populations in clinical trials. This initiative aims to ensure meaningful representation of diverse communities in the development of improved treatments and strategies to combat diseases. Robust funding and investments from both public and private agencies for the rapid and innovative development of COVID-19 diagnostics are expected to further boost the market for COVID-19 rapid test kits.

The anticipated expansion of the COVID-19 rapid test kits market is also driven by the rising healthcare expenditure. Healthcare expenditure, representing the total spending on healthcare-related goods and services within a healthcare system or economy, plays a crucial role in supporting the development and accessibility of COVID-19 rapid test kits. For instance, according to the Canadian Institute for Health Information in November 2022, healthcare expenditure increased to 0.8%, totaling $331 billion in 2022, compared to 7.6% in 2021. The upward trend in healthcare expenditure is a significant driver of the growth in the COVID-19 rapid test kits market.

The integration of Artificial Intelligence (AI) algorithms with rapid diagnostic test kits is expected to be a significant driver of market growth during the forecast period. An example of this trend is Mylab, an India-based biotechnology company, which, in May 2021, launched the first self-use rapid antigen test for COVID-19 approved by the Indian Council of Medical Research (ICMR), a government agency in India. This test incorporates AI-powered mobile app functionality that not only provides users with their test results but also submits the results directly to ICMR for traceability.

Major companies in the COVID-19 rapid test kits market are actively developing innovative self-use rapid antigen test kits utilizing lateral flow technology to enhance market revenues. Abbott, a prominent U.S.-based medical device company, is utilizing lateral flow technology, a well-established and widely used method in rapid diagnostic testing. In July 2021, Abbott launched the Panbio COVID-19 antigen self-test, leveraging its lateral flow technology. This test kit employs a minimally invasive nasal swab and can deliver results in as little as 15 minutes, requiring no additional instrumentation. The adoption of AI algorithms and lateral flow technology in the development of rapid test kits is poised to contribute significantly to the efficiency and accuracy of COVID-19 testing, thereby driving market growth.

In June 2023, Avacta, a UK-based biotechnology company, completed the acquisition of Coris Bioconcept for an undisclosed sum. This strategic move by Avacta is intended to broaden its diagnostics portfolio, offering inventive solutions to the healthcare sector. Coris Bioconcept, located in Belgium, specializes in the production of COVID-19 rapid test kits.

Major companies operating in the COVID-19 rapid test kits market report are Abbott Laboratories, F. Hoffmann-La Roche Ag, Becton, Dickinson and Company, Siemens Healthineers Ag, Quidel Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Quest Diagnostics, QIAGEN N.V., DiaSorin S.p.A., Mylab Discovery Solutions, Kalbe Farma, He Qi Group Foundation, Beijing Jinwofu Bioengineering Technology Company, Zhejiang Orient Gene Biotech Co. Ltd., Transasia Bio Medicals, Vanguard Diagnostics, HLL Lifecare Limited, Voxtur Bio Ltd., LAB-CARE Diagnostics, ImmunoScience, CPC Diagnostics, Seegene, SD Biosensor, Getein Biotech, Hangzhou Biotest Biotech, Boditech Med, Inc., Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, Vivacheck Lab, Fujirebio, Sysmex Corporation, Atomo Diagnostics, Cellmid Limited, Senova, CerTest Biotec, Omega Diagnostics, Abingdon Health, Babylon, Novacyt Group, BioMaxima S.A, SensDx S.A, OraSure Technologies, Inc., Sorrento Therapeutics, Monocent Inc., Aurora Biomed, Hologic, LabCorp, GenMark Diagnostics, BioFire Diagnostics, Mesa Biotech, Perkin Elmer, Healgen Scientific Limited Liability Company, NTBIO DiagnosticsVictory Square Health, Motologic, LetsGetChecked, ACRO Biotech, Cellex Inc., Advagen Biotech Ltd., BATM, BioMedomics QuantLease, CapeBio

North America was the largest region in the COVID-19 rapid test kits market in 2023. Western Europe was the second largest region in the global COVID-19 rapid test kits market share. The regions covered in the COVID-19 rapid test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the COVID-19 rapid test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The COVID-19 rapid test kits market consists of sales of molecular test kits and antigen test kits. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

COVID-19 Rapid Test Kits Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on covid-19 rapid test kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for covid-19 rapid test kits? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The covid-19 rapid test kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Scope

Markets Covered:

Table of Contents

1. Executive Summary

2. COVID-19 Rapid Test Kits Market Characteristics

3. COVID-19 Rapid Test Kits Market Trends And Strategies

4. COVID-19 Rapid Test Kits Market - Macro Economic Scenario

5. Global COVID-19 Rapid Test Kits Market Size and Growth

6. COVID-19 Rapid Test Kits Market Segmentation

7. COVID-19 Rapid Test Kits Market Regional And Country Analysis

8. Asia-Pacific COVID-19 Rapid Test Kits Market

9. China COVID-19 Rapid Test Kits Market

10. India COVID-19 Rapid Test Kits Market

11. Japan COVID-19 Rapid Test Kits Market

12. Australia COVID-19 Rapid Test Kits Market

13. Indonesia COVID-19 Rapid Test Kits Market

14. South Korea COVID-19 Rapid Test Kits Market

15. Western Europe COVID-19 Rapid Test Kits Market

16. UK COVID-19 Rapid Test Kits Market

17. Germany COVID-19 Rapid Test Kits Market

18. France COVID-19 Rapid Test Kits Market

19. Italy COVID-19 Rapid Test Kits Market

20. Spain COVID-19 Rapid Test Kits Market

21. Eastern Europe COVID-19 Rapid Test Kits Market

22. Russia COVID-19 Rapid Test Kits Market

23. North America COVID-19 Rapid Test Kits Market

24. USA COVID-19 Rapid Test Kits Market

25. Canada COVID-19 Rapid Test Kits Market

26. South America COVID-19 Rapid Test Kits Market

27. Brazil COVID-19 Rapid Test Kits Market

28. Middle East COVID-19 Rapid Test Kits Market

29. Africa COVID-19 Rapid Test Kits Market

30. COVID-19 Rapid Test Kits Market Competitive Landscape And Company Profiles

31. COVID-19 Rapid Test Kits Market Other Major And Innovative Companies

32. Global COVID-19 Rapid Test Kits Market Competitive Benchmarking

33. Global COVID-19 Rapid Test Kits Market Competitive Dashboard

34. Key Mergers And Acquisitions In The COVID-19 Rapid Test Kits Market

35. COVID-19 Rapid Test Kits Market Future Outlook and Potential Analysis

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기